Genetron Holdings, Ltd. engages in precision oncology. It provides cancer molecular profiling by using technologies in molecular biology and data science to transform cancer treatment. It products and services include diagnosis and monitoring through both LDT and IVD products. Its LDT portfolio consists of both specifically designed focused and comprehensive gene panel testing services. It also develops liver cancer early screening products. The company was founded by Si Zhen Wang, Hai Yan, and Wei Wu He in 2015 and is headquartered in Beijing, China.
Sector:
Health Services
Industry:
Medical Or Nursing Services
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Genetron Holdings Ltd - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Genetron Holdings Ltd - ADR market cap is $127.29M.
What is the 52-week high for Genetron Holdings Ltd - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Genetron Holdings Ltd - ADR 52 week high is $4.03 as of October 10, 2025.
What is the 52-week low for Genetron Holdings Ltd - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Genetron Holdings Ltd - ADR 52 week low is $4.03 as of October 10, 2025.
What is Genetron Holdings Ltd - ADR stock price today?
Genetron Holdings Ltd - ADR stock price today is $4.03.
What was Genetron Holdings Ltd - ADR stock price yesterday?
Genetron Holdings Ltd - ADR stock price yesterday was $4.02.
What is the 50-day moving average of Genetron Holdings Ltd - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Genetron Holdings Ltd - ADR 50-day moving average is $4.03.